HYTN Awarded Controlled Drugs and Substances Dealer's License Allowing for Production and Sale of Psilocybin
globenewswire.com
news
2022-10-17 00:00:00

VANCOUVER, British Columbia, Oct. 17, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. ('HYTN' or the 'Company') (CSE: HYTN), a leading cannabis company focused on creating consistent, natural and delicious cannabis products, is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a Controlled Drugs and Substances Dealer's Licence (the 'License') by Health Canada allowing for the sale, possession, production, assembly and transportation of psilocybin, a naturally occurring psychedelic prodrug compound produced by a number of  fungi.
